27 July 2020 - The coronavirus disease 2019 (COVID-19) pandemic has led to a massive activation of clinical research. 

The methodological strength of these studies is not well characterised but has implications for the quality of evidence produced.

Pundi and colleagues have evaluated the characteristics and expected strength of evidence of COVID-19 studies registered on ClinicalTrials.gov.

Read JAMA article